A cell-based luciferase-dependent assay for the quantitative determination of free extracellular adenosine with paracrine signaling activity

Journal of Immunological Methods

Volumn 361, Issue 1-2, 2010, Pages 51-56

  Häusler, Sebastian F M ^a   Ossadnik, Monika ^a   Horn, Evi ^a   Heuer, Stefan ^a   Dietl, Johannes ^a   Wischhusen, Jörg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adenosine signaling; Luciferase reporter assay; Regulatory T cells; Tolerogenic microenvironment

Indexed keywords

ADENOSINE; ADENOSINE A2 RECEPTOR; CYCLIC AMP; DIPYRIDAMOLE; LUCIFERASE; NUCLEOSIDE; ADENOSINE RECEPTOR;

ARTICLE; CELL ASSAY; CELL STRAIN HEK293; COST EFFECTIVENESS ANALYSIS; EMBRYO; HUMAN; HUMAN CELL; LUMINESCENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REGULATORY T LYMPHOCYTE; SENSITIVITY ANALYSIS; CELL LINE; EXTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ADENOSINE; CELL LINE; DIPYRIDAMOLE; EXTRACELLULAR SPACE; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS; RECEPTORS, PURINERGIC P1; SIGNAL TRANSDUCTION;

EID: 77956886046     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.07.011     Document Type: Article

References (23)

1. Chepurny O.G., Holz G.G. A novel cyclic adenosine monophosphate responsive luciferase reporter incorporating a nonpalindromic cyclic adenosine monophosphate response element provides optimal performance for use in G protein coupled receptor drug discovery efforts. J. Biomol. Screen. 2007, 12:740.
2. Ciruela F., Saura C., Canela E.I., Mallol J., Lluis C., Franco R. Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett. 1996, 380:219.
3. Deaglio S., Dwyer K.M., Gao W., Friedman D., Usheva A., Erat A., Chen J.F., Enjyoji K., Linden J., Oukka M., Kuchroo V.K., Strom T.B., Robson S.C. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007, 204:1257.
4. Dyer B.W., Ferrer F.A., Klinedinst D.K., Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal. Biochem. 2000, 282:158.
5. Eckle T., Füllbier L., Wehrmann M., Khoury J., Mittelbronn M., Ibla J., Rosenberger P., Eltzschig H.K. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 2007, 178:8127.
6. Eckle T., Krahn T., Grenz A., Kohler D., Mittelbronn M., Ledent C., Jacobson M.A., Osswald H., Thompson L.F., Unertl K., Eltzschig H.K. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007, 115:1581.
7. Eckle T., Grenz A., Laucher S., Eltzschig H.K. A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest. 2008, 118:3301.
8. Eltzschig H.K., Abdulla P., Hoffman E., Hamilton K.E., Daniels D., Schonfeld C., Loffler M., Reyes G., Duszenko M., Karhausen J., Robinson A., Westerman K.A., Coe I.R., Colgan S.P. HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J. Exp. Med. 2005, 202:1493.
9. Eltzschig H.K., Rivera-Nieves J., Colgan S.P. Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert Opin. Ther. Targets 2009, 13:1267.
10. Fishman P., Bar-Yehuda S., Synowitz M., Powell J.D., Klotz K.N., Gessi S., Borea P.A. Adenosine receptors and cancer. Handb. Exp. Pharmacol. 2009, 193:399.
11. Gaspar H.B., Aiuti A., Porta F., Candotti F., Hershfield M.S., Notarangelo L.D. How I treat ADA deficiency. Blood 2009, 114:3524.
12. Grenz A., Osswald H., Eckle T., Yang D., Zhang H., Tran Z.V., Klingel K., Ravid K., Eltzschig H.K. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med. 2008, 5:e137.
13. Klotz K.N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedebergs Arch. Pharmacol. 1998, 357:1.
14. + regulatory T cells(TREG). J Biol Chem 2010, 285:7176.
15. Morote-Garcia J.C., Rosenberger P., Nivillac N.M., Coe I.R., Eltzschig H.K. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology 2009, 136:607.
16. Nilsson K.F., Grishina V.A., Glaumann C., Gustafsson L.E. Estimation of endogenous adenosine activity at adenosine receptors in guinea-pig ileum using a new pharmacological method. Acta Physiol. (Oxf) 2010, 30.
17. Oberg H.H., Wesch D., Lenke J., Kabelitz D. An optimized method for the functional analysis of human regulatory T cells. Scand. J. Immunol. 2006, 64:353.
18. Schingnitz U., Hartmann K., Macmanus C.F., Eckle T., Zug S., Colgan S.P., Eltzschig H.K. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 2010, 184:5271.
19. Schulte G., Fredholm B.B. Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2. Mol. Pharmacol. 2000, 58:477.
20. Schulte G., Fredholm B.B. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal. 2003, 15:813.
21. Shinde R., Perkins J., Contag C.H. Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays. Biochemistry 2006, 45:11103.
22. Simone M.M., Joaquim C.G.E.d.S. Firefly bioluminescence: a mechanistic approach of luciferase catalyzed reactions. IUBMB Life 2009, 61:6.
23. Stagg J., Divisekera U., McLaughlin N., Sharkey J., Pommey S., Denoyer D., Dwyer K.M., Smyth M.J. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1547.